ZENTEL VERSUS FENTEL: HC restrains manufacture, sale of medicine for violation of trademark Farhat Nasim6 Oct 2019 11:10 AM ISTNew Delhi: In a relief to the pharmaceutical giant in a trademark matter, the Delhi High Court has recently restrained the manufacture or sale of...
SPARC neonatal seizures drug Phenobarbital gets Orphan Drug Designation from USFDA Farhat Nasim5 Oct 2019 12:00 PM ISTOrphan Drug Designation will grant seven years of US market exclusivity upon approval of Phenobarbital for the treatment of patients with neonatal...
Alembic JV Aleor Derma gets USFDA nod for therapeutic equivalent of Clobex Spray Farhat Nasim4 Oct 2019 12:40 PM ISTClobetasol Propionate Spray, 0.05% is indicated for the treatment of moderate to severe plaque psoriasis affecting up to 20% body surface area (BSA)...
Sreeji Gopinathan joins Lupin as Chief Information Officer Medical Dialogues Bureau3 Oct 2019 4:03 PM ISTMumbai, October 03, 2019: Pharma major Lupin Limited announced today the appointment of Sreeji Gopinathan as Chief Information Officer (CIO). He will...
Lupin clears Japanese regulator PMDA inspection of Goa facility Farhat Nasim2 Oct 2019 9:50 AM ISTThe Pharmaceutical and Medical Devices Agency (PMDA), Japan, has completed the Good Manufacturing Practice inspection of the company's Goa facility...
Natco Pharma Mekaguda facility gets EIR from USFDA Farhat Nasim1 Oct 2019 3:57 PM ISTHyderabad: Drug firm Natco Pharma today said it has received Establishment Inspection Report (EIR) from the US health regulator for its Active...
Cadila Healthcare to sell right of cholesterol-lowering drug Zypitamag for Rs 49 crore Farhat Nasim1 Oct 2019 2:13 PM ISTThe company has entered into an asset purchase agreement to sell its right, title and interest in Zypitamag, along with applicable registrations and...
Cipla gets 12 USFDA observations for Goa facility Medical Dialogues Bureau30 Sept 2019 3:15 PM IST"The United States Food and Drug Administration (USFDA) conducted a cGMP inspection at our Goa manufacturing facility from September 16-27, 2019,"...
Mylan to infuse USD 1 billion on capex in India Medical Dialogues Bureau30 Sept 2019 9:30 AM ISTMylan Global President and Executive Director Rajiv Malik said the company had been investing close to about USD 400 million or USD 450 million...
OncoStem Diagnostics named 'Best Innovation- Cancer Risk Assessment' by NASSCOM Life sciences and healthcare innovation forum Medical Dialogues Bureau29 Sept 2019 9:57 AM ISTBangalore, : OncoStem Diagnostics, an Oncology focused company that enables personalised cancer treatment was named as 'Best Innovation- Cancer Risk...
Strides Pharma gets USFDA nod for generic version of Vesicare Tablets to treat overactive bladder Medical Dialogues Bureau28 Sept 2019 2:38 PM IST"Solifenacin Succinate Tablet is a generic version of Vesicare Tablets, 5 mg and 10 mg, of Astellas Pharma US, Inc, " Strides Pharma said.Bangalore:...
CDSCO warns against Cancer Causing Impurities in anti-acidity drug Ranitidine, writes to state drug controllers Farhat Nasim25 Sept 2019 1:19 PM ISTNew Delhi: To ensure patient safety, the country's apex drug regulatory body, Central Drugs Standard Control Organisation (CDSCO) has ordered an...
